TP53 and metastatic neoplasm: There also is evidence that genetic alterations in TP53 and TGF-beta signaling might predict the pattern of metastatic progression.28 Interestingly, after metastasectomy, the recurrence of metastatic disease occurs in the same organ in most cases, supporting the concept of molecular programing for metastatic disease.29